Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Microbiome of the Eye01:22

Microbiome of the Eye

The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deconstructing White Dot Syndromes-Multimodal Imaging in Uveitis (MUV) Taskforce: Report 11.

American journal of ophthalmology·2026
Same author

EULAR recommendations for the management of Behçet's syndrome: 2025 update.

Annals of the rheumatic diseases·2026
Same author

Uveitis as a Disguise - Masquerade Syndromes in the Modern Era.

Ocular immunology and inflammation·2026
Same author

Adalimumab-Induced Changes in NK Cells Phenotype, Receptors, and Functions After Clinical Remission of Behçet's Uveitis.

American journal of ophthalmology·2026
Same author

Behçet disease: A unique systemic vasculitis with a distinct form of ocular involvement.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society·2025
Same author

Monitoring Behçet uveitis.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society·2025

Related Experiment Video

Updated: Jun 13, 2026

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

Behçet's Uveitis.

Ilknur Tugal-Tutkun1

  • 1Department of Ophthalmology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.

Middle East African Journal of Ophthalmology
|April 21, 2010
PubMed
Summary
This summary is machine-generated.

Behçet's disease, a Silk Road inflammatory disorder, often affects the eyes with relapsing panuveitis. Early, aggressive immunomodulatory therapy improves visual prognosis in affected patients.

Keywords:
Behçet's DiseaseImmunomodulatory TreatmentRetinal VasculitisUveitis

More Related Videos

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

Related Experiment Videos

Last Updated: Jun 13, 2026

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

Area of Science:

  • Ophthalmology
  • Rheumatology
  • Immunology

Background:

  • Behçet's disease is a multisystem inflammatory disorder prevalent along the Silk Road.
  • Ocular involvement, typically relapsing panuveitis and retinal vasculitis, is common and impacts vision.
  • Uveitis is an early sign in 10-15% of patients, with anterior uveitis being nongranulomatous.

Purpose of the Study:

  • To summarize the key aspects of ocular involvement in Behçet's disease.
  • To highlight diagnostic features and monitoring tools for ocular inflammation.
  • To discuss current therapeutic strategies and their impact on visual prognosis.

Main Methods:

  • Review of clinical manifestations of ocular Behçet's disease.
  • Description of diagnostic techniques including fundus fluorescein angiography and laser flare photometry.
  • Summary of treatment modalities, including corticosteroids, azathioprine, cyclosporine, and biologic agents.

Main Results:

  • Posterior segment inflammation presents with vitritis, retinal infiltrates, and vasculitis, often resolving spontaneously.
  • Common complications include cataract, maculopathy, and optic atrophy.
  • Male patients experience a more severe disease course and poorer visual outcomes.

Conclusions:

  • Early and aggressive immunomodulatory therapy, including biologic agents for resistant cases, has improved visual prognosis.
  • Effective management requires prompt diagnosis and treatment of ocular manifestations.
  • Continued research into optimal therapeutic strategies is crucial for managing Behçet's disease-related eye conditions.